VRTX240426P00415000 Option on Vertex Pharmaceuticals
| VRTX Stock | USD 418.82 8.58 2.09% |
Vertex Pharmaceuticals' option chain provides insight into all available option contracts written on Vertex Pharmaceuticals' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Vertex Pharmaceuticals' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Vertex option contract.
In The Money vs. Out of Money Option Contracts on Vertex Pharmaceuticals
Analyzing Vertex Pharmaceuticals' in-the-money options over time can help investors to take a profitable long position in Vertex Pharmaceuticals regardless of its overall volatility. This is especially true when Vertex Pharmaceuticals' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Vertex Pharmaceuticals' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Vertex Pharmaceuticals' stock while costing only a fraction of its price.
Vertex Pharmaceuticals' latest option contracts expiring on 2024-05-10 are carrying combined implied volatility of 37.8 with a put-to-call open interest ratio of 1.0 over 140 outstanding agreements suggesting investors are buying slightly more puts than calls on contracts expiring on 2024-05-10. The current put volume is at 2061, with calls trading at the volume of 1922. This yields a 1.07 put-to-call volume ratio. The Vertex Pharmaceuticals option chain provides detailed quote and price information for the current Vertex Pharmaceuticals option contracts. It shows all of Vertex Pharmaceuticals' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-10 Option Contracts
Vertex Pharmaceuticals option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Vertex Pharmaceuticals' lending market. For example, when Vertex Pharmaceuticals' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Vertex Pharmaceuticals, he or she must hedge the risk by shorting Vertex Pharmaceuticals stock over its option's life.
2024-05-10
The chart above shows Vertex Pharmaceuticals' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Vertex Pharmaceuticals' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Vertex Pharmaceuticals' option, there is no secondary market available for investors to trade.
Vertex Pharmaceuticals Maximum Pain Price across 2024-05-10 Option Contracts
Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of particular securities such as Vertex Pharmaceuticals close to expiration to expire worthless. According to most research, approximately 10% to 15% of all stock options are exercised, while about 35% expire worthlessly, with roughly 50% traded out before the expiration date. So, Max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.
Vertex Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of Vertex Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Vertex stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Vertex Pharmaceuticals' stock price goes up or down, the stock options follow.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. Please note that buying 'in-the-money' options on Vertex Pharmaceuticals lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Vertex Pharmaceuticals' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Vertex Pharmaceuticals contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Vertex Stock moves the wrong way.
At this time, Vertex Pharmaceuticals' Total Stockholder Equity is fairly stable compared to the past year. Liabilities And Stockholders Equity is likely to rise to about 23.9 B in 2024, whereas Common Stock Shares Outstanding is likely to drop slightly above 153.1 M in 2024. Vertex Pharmaceuticals In The Money Call Balance
When Vertex Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Vertex Pharmaceuticals stock is said to be in the money. When it comes to buying Vertex Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Vertex Pharmaceuticals are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Vertex Current Options Market Mood
Vertex Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Vertex Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Vertex Pharmaceuticals' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Vertex Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Vertex Pharmaceuticals' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Vertex contract
Base on the Rule 16, the options market is currently suggesting that Vertex Pharmaceuticals will have an average daily up or down price movement of about 2.36% per day over the life of the 2024-05-10 option contract. With Vertex Pharmaceuticals trading at USD 418.82, that is roughly USD 9.89. If you think that the market is fully incorporating Vertex Pharmaceuticals' daily price movement you should consider buying Vertex Pharmaceuticals options at the current volatility level of 37.8%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Vertex |
Purchasing Vertex Pharmaceuticals options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Vertex calls. Remember, the seller must deliver Vertex Pharmaceuticals stock to the call owner when a call is exercised.
Vertex Pharmaceuticals Option Chain
When Vertex Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Vertex Pharmaceuticals stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
2024-05-102024-05-172024-05-242024-05-312024-06-072024-06-142024-06-212024-07-192024-09-202024-10-182025-01-172025-06-202026-01-162026-06-182026-12-18
Vertex Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Vertex. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Vertex. It also shows strike prices and maturity days for a Vertex Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-10 CALL at $220.0 | 0.9485 | 6.0E-4 | 0 | 2024-05-10 | 185.5 - 195.0 | 0.0 | In |
Call | 2024-05-10 CALL at $230.0 | 0.9452 | 7.0E-4 | 0 | 2024-05-10 | 175.2 - 185.0 | 0.0 | In |
Call | 2024-05-10 CALL at $240.0 | 0.9417 | 7.0E-4 | 0 | 2024-05-10 | 165.4 - 175.0 | 0.0 | In |
Call | 2024-05-10 CALL at $250.0 | 0.9379 | 8.0E-4 | 0 | 2024-05-10 | 155.5 - 165.0 | 0.0 | In |
Call | 2024-05-10 CALL at $255.0 | 0.9359 | 9.0E-4 | 0 | 2024-05-10 | 150.1 - 160.0 | 0.0 | In |
Call | 2024-05-10 CALL at $260.0 | 0.9338 | 9.0E-4 | 0 | 2024-05-10 | 145.5 - 155.0 | 0.0 | In |
Call | 2024-05-10 CALL at $265.0 | 0.9316 | 0.001 | 0 | 2024-05-10 | 140.1 - 150.0 | 0.0 | In |
Call | 2024-05-10 CALL at $270.0 | 0.9294 | 0.001 | 0 | 2024-05-10 | 135.2 - 145.0 | 0.0 | In |
Call | 2024-05-10 CALL at $275.0 | 0.9269 | 0.0011 | 0 | 2024-05-10 | 130.5 - 140.0 | 0.0 | In |
Call | 2024-05-10 CALL at $280.0 | 0.9244 | 0.0012 | 10 | 2024-05-10 | 125.1 - 135.0 | 123.6 | In |
Call | 2024-05-10 CALL at $285.0 | 0.9227 | 0.0012 | 0 | 2024-05-10 | 120.1 - 129.9 | 0.0 | In |
Call | 2024-05-10 CALL at $290.0 | 0.9189 | 0.0013 | 10 | 2024-05-10 | 115.3 - 125.0 | 113.56 | In |
Call | 2024-05-10 CALL at $295.0 | 0.916 | 0.0014 | 0 | 2024-05-10 | 110.4 - 120.0 | 0.0 | In |
Call | 2024-05-10 CALL at $300.0 | 0.9754 | 8.0E-4 | 1 | 2024-05-10 | 105.0 - 114.9 | 111.0 | In |
Call | 2024-05-10 CALL at $305.0 | 0.9106 | 0.0016 | 0 | 2024-05-10 | 100.2 - 109.9 | 0.0 | In |
Call | 2024-05-10 CALL at $310.0 | 0.9059 | 0.0017 | 0 | 2024-05-10 | 95.3 - 105.0 | 0.0 | In |
Call | 2024-05-10 CALL at $315.0 | 0.9021 | 0.0019 | 0 | 2024-05-10 | 90.4 - 100.0 | 0.0 | In |
Call | 2024-05-10 CALL at $320.0 | 0.8992 | 0.002 | 0 | 2024-05-10 | 85.3 - 94.9 | 0.0 | In |
Call | 2024-05-10 CALL at $325.0 | 0.9891 | 7.0E-4 | 0 | 2024-05-10 | 81.0 - 90.0 | 0.0 | In |
Call | 2024-05-10 CALL at $330.0 | 0.9885 | 7.0E-4 | 0 | 2024-05-10 | 76.0 - 85.0 | 0.0 | In |
Call | 2024-05-10 CALL at $335.0 | 0.9879 | 8.0E-4 | 0 | 2024-05-10 | 71.0 - 80.0 | 0.0 | In |
Call | 2024-05-10 CALL at $340.0 | 0.9905 | 8.0E-4 | 0 | 2024-05-10 | 67.0 - 73.9 | 0.0 | In |
Call | 2024-05-10 CALL at $345.0 | 0.9899 | 9.0E-4 | 0 | 2024-05-10 | 61.5 - 69.4 | 0.0 | In |
Call | 2024-05-10 CALL at $350.0 | 0.9735 | 0.0018 | 0 | 2024-05-10 | 57.0 - 64.4 | 0.0 | In |
Call | 2024-05-10 CALL at $355.0 | 0.9846 | 0.0014 | 0 | 2024-05-10 | 51.8 - 59.2 | 0.0 | In |
Call | 2024-05-10 CALL at $360.0 | 0.9835 | 0.0016 | 0 | 2024-05-10 | 46.8 - 54.2 | 0.0 | In |
Call | 2024-05-10 CALL at $365.0 | 0.9779 | 0.0022 | 0 | 2024-05-10 | 42.0 - 49.1 | 0.0 | In |
Call | 2024-05-10 CALL at $370.0 | 0.8515 | 0.0054 | 1 | 2024-05-10 | 37.0 - 43.8 | 37.35 | In |
Call | 2024-05-10 CALL at $375.0 | 0.9602 | 0.004 | 5 | 2024-05-10 | 32.2 - 39.2 | 24.59 | In |
Call | 2024-05-10 CALL at $380.0 | 0.8428 | 0.0074 | 19 | 2024-05-10 | 26.8 - 34.3 | 33.14 | In |
Call | 2024-05-10 CALL at $385.0 | 0.7898 | 0.0084 | 7 | 2024-05-10 | 22.1 - 29.6 | 22.2 | In |
Call | 2024-05-10 CALL at $387.5 | 0.9632 | 0.0061 | 5 | 2024-05-10 | 19.3 - 26.8 | 18.5 | In |
Call | 2024-05-10 CALL at $390.0 | 0.774 | 0.0103 | 10 | 2024-05-10 | 16.8 - 24.3 | 19.5 | In |
Call | 2024-05-10 CALL at $392.5 | 0.7704 | 0.0118 | 4 | 2024-05-10 | 14.6 - 21.4 | 17.0 | In |
Call | 2024-05-10 CALL at $395.0 | 0.7472 | 0.013 | 14 | 2024-05-10 | 11.9 - 19.2 | 13.82 | In |
Call | 2024-05-10 CALL at $397.5 | 0.7644 | 0.0164 | 19 | 2024-05-10 | 9.7 - 17.1 | 15.5 | In |
Call | 2024-05-10 CALL at $400.0 | 0.7421 | 0.0194 | 91 | 2024-05-10 | 9.0 - 13.0 | 9.9 | In |
Call | 2024-05-10 CALL at $402.5 | 0.8737 | 0.0297 | 116 | 2024-05-10 | 5.0 - 9.6 | 8.3 | In |
Call | 2024-05-10 CALL at $405.0 | 0.7408 | 0.0382 | 148 | 2024-05-10 | 5.3 - 7.4 | 6.7 | In |
Call | 2024-05-10 CALL at $407.5 | 0.6465 | 0.0475 | 85 | 2024-05-10 | 4.1 - 6.5 | 4.75 | In |
Call | 2024-05-10 CALL at $410.0 | 0.5226 | 0.0527 | 1017 | 2024-05-10 | 2.9 - 3.7 | 3.2 | In |
Call | 2024-05-10 CALL at $412.5 | 0.3764 | 0.0575 | 65 | 2024-05-10 | 1.4 - 2.9 | 1.71 | Out |
Call | 2024-05-10 CALL at $415.0 | 0.2589 | 0.046 | 61 | 2024-05-10 | 0.4 - 1.95 | 1.09 | Out |
Call | 2024-05-10 CALL at $417.5 | 0.167 | 0.0345 | 65 | 2024-05-10 | 0.2 - 1.45 | 0.64 | Out |
Call | 2024-05-10 CALL at $420.0 | 0.0914 | 0.0231 | 504 | 2024-05-10 | 0.15 - 0.5 | 0.3 | Out |
Call | 2024-05-10 CALL at $425.0 | 0.0537 | 0.0123 | 164 | 2024-05-10 | 0.0 - 0.65 | 0.2 | Out |
Call | 2024-05-10 CALL at $430.0 | 0.0227 | 0.0056 | 404 | 2024-05-10 | 0.05 - 0.1 | 0.08 | Out |
Call | 2024-05-10 CALL at $435.0 | 0.0113 | 0.0028 | 219 | 2024-05-10 | 0.0 - 0.05 | 0.04 | Out |
Call | 2024-05-10 CALL at $440.0 | 0.0117 | 0.0024 | 84 | 2024-05-10 | 0.0 - 0.1 | 0.05 | Out |
Call | 2024-05-10 CALL at $445.0 | 0.0104 | 0.0019 | 67 | 2024-05-10 | 0.0 - 1.3 | 0.05 | Out |
Call | 2024-05-10 CALL at $450.0 | 0.0094 | 0.0016 | 220 | 2024-05-10 | 0.0 - 0.05 | 0.05 | Out |
Put | 2024-05-10 PUT at $270.0 | -0.0211 | 6.0E-4 | 10 | 2024-05-10 | 0.0 - 3.8 | 0.75 | Out |
Put | 2024-05-10 PUT at $280.0 | -0.0229 | 7.0E-4 | 10 | 2024-05-10 | 0.0 - 4.2 | 0.76 | Out |
Put | 2024-05-10 PUT at $350.0 | -0.0058 | 6.0E-4 | 124 | 2024-05-10 | 0.0 - 0.05 | 0.05 | Out |
Put | 2024-05-10 PUT at $360.0 | -0.0068 | 9.0E-4 | 140 | 2024-05-10 | 0.05 - 0.2 | 0.05 | Out |
Put | 2024-05-10 PUT at $365.0 | -0.0075 | 0.001 | 62 | 2024-05-10 | 0.0 - 0.05 | 0.05 | Out |
Put | 2024-05-10 PUT at $370.0 | -0.0142 | 0.0018 | 120 | 2024-05-10 | 0.05 - 0.1 | 0.1 | Out |
Put | 2024-05-10 PUT at $375.0 | -0.0121 | 0.0019 | 265 | 2024-05-10 | 0.05 - 0.1 | 0.07 | Out |
Put | 2024-05-10 PUT at $380.0 | -0.018 | 0.0029 | 569 | 2024-05-10 | 0.05 - 0.15 | 0.1 | Out |
Put | 2024-05-10 PUT at $385.0 | -0.0192 | 0.0037 | 88 | 2024-05-10 | 0.05 - 0.2 | 0.09 | Out |
Put | 2024-05-10 PUT at $387.5 | -0.0359 | 0.006 | 30 | 2024-05-10 | 0.0 - 1.6 | 0.19 | Out |
Put | 2024-05-10 PUT at $390.0 | -0.0583 | 0.0087 | 122 | 2024-05-10 | 0.05 - 1.1 | 0.34 | Out |
Put | 2024-05-10 PUT at $392.5 | -0.0588 | 0.01 | 50 | 2024-05-10 | 0.0 - 1.1 | 0.3 | Out |
Put | 2024-05-10 PUT at $395.0 | -0.0874 | 0.0136 | 975 | 2024-05-10 | 0.15 - 0.8 | 0.05 | Out |
Put | 2024-05-10 PUT at $397.5 | -0.0581 | 0.0139 | 20 | 2024-05-10 | 0.0 - 0.65 | 0.21 | Out |
Put | 2024-05-10 PUT at $400.0 | -0.0915 | 0.0207 | 243 | 2024-05-10 | 0.0 - 0.75 | 0.34 | Out |
Put | 2024-05-10 PUT at $402.5 | -0.1885 | 0.0298 | 114 | 2024-05-10 | 0.45 - 1.1 | 0.95 | Out |
Put | 2024-05-10 PUT at $405.0 | -0.2306 | 0.0412 | 139 | 2024-05-10 | 0.0 - 1.75 | 1.0 | Out |
Put | 2024-05-10 PUT at $407.5 | -0.3438 | 0.0508 | 7 | 2024-05-10 | 0.0 - 3.4 | 1.68 | Out |
Put | 2024-05-10 PUT at $410.0 | -0.4798 | 0.0486 | 125 | 2024-05-10 | 2.4 - 3.2 | 3.11 | Out |
Put | 2024-05-10 PUT at $412.5 | -0.6947 | 0.0832 | 3 | 2024-05-10 | 2.85 - 4.6 | 3.0 | In |
Put | 2024-05-10 PUT at $415.0 | -0.6154 | 0.0257 | 101 | 2024-05-10 | 1.85 - 8.6 | 3.5 | In |
Put | 2024-05-10 PUT at $417.5 | -0.8525 | 0.0343 | 0 | 2024-05-10 | 4.2 - 11.2 | 0.0 | In |
Put | 2024-05-10 PUT at $420.0 | -0.6978 | 0.0197 | 100 | 2024-05-10 | 6.3 - 13.0 | 6.8 | In |
Put | 2024-05-10 PUT at $425.0 | -0.7296 | 0.0147 | 0 | 2024-05-10 | 11.3 - 18.3 | 12.9 | In |
Put | 2024-05-10 PUT at $430.0 | -0.7582 | 0.0119 | 0 | 2024-05-10 | 15.8 - 23.3 | 0.0 | In |
Put | 2024-05-10 PUT at $435.0 | -0.7686 | 0.0098 | 0 | 2024-05-10 | 20.8 - 28.7 | 0.0 | In |
Put | 2024-05-10 PUT at $440.0 | -0.7963 | 0.0086 | 0 | 2024-05-10 | 25.8 - 33.3 | 0.0 | In |
Put | 2024-05-10 PUT at $445.0 | -0.9601 | 0.0046 | 5 | 2024-05-10 | 31.3 - 38.7 | 42.76 | In |
Put | 2024-05-10 PUT at $450.0 | -0.9592 | 0.0041 | 5 | 2024-05-10 | 36.5 - 43.6 | 47.62 | In |
Put | 2024-05-10 PUT at $455.0 | -0.9349 | 0.0046 | 0 | 2024-05-10 | 42.4 - 48.5 | 0.0 | In |
Put | 2024-05-10 PUT at $460.0 | -0.8389 | 0.0055 | 0 | 2024-05-10 | 46.0 - 53.3 | 0.0 | In |
Put | 2024-05-10 PUT at $465.0 | -0.9903 | 0.0012 | 0 | 2024-05-10 | 51.3 - 58.3 | 0.0 | In |
Put | 2024-05-10 PUT at $470.0 | -0.8547 | 0.0046 | 0 | 2024-05-10 | 56.2 - 63.2 | 0.0 | In |
Put | 2024-05-10 PUT at $475.0 | -0.9859 | 0.0013 | 0 | 2024-05-10 | 60.8 - 68.9 | 0.0 | In |
Put | 2024-05-10 PUT at $480.0 | -0.9865 | 0.0012 | 0 | 2024-05-10 | 65.8 - 73.9 | 0.0 | In |
Put | 2024-05-10 PUT at $485.0 | -0.9643 | 0.0021 | 0 | 2024-05-10 | 71.6 - 78.8 | 0.0 | In |
Put | 2024-05-10 PUT at $490.0 | -0.8781 | 0.0034 | 0 | 2024-05-10 | 75.6 - 83.0 | 0.0 | In |
Put | 2024-05-10 PUT at $495.0 | -0.9928 | 6.0E-4 | 0 | 2024-05-10 | 80.0 - 89.6 | 0.0 | In |
Put | 2024-05-10 PUT at $500.0 | -0.9849 | 0.001 | 0 | 2024-05-10 | 85.2 - 94.6 | 0.0 | In |
Put | 2024-05-10 PUT at $505.0 | -0.9934 | 5.0E-4 | 0 | 2024-05-10 | 90.0 - 99.6 | 0.0 | In |
Put | 2024-05-10 PUT at $510.0 | -0.9936 | 5.0E-4 | 0 | 2024-05-10 | 95.0 - 104.6 | 0.0 | In |
Put | 2024-05-10 PUT at $520.0 | -0.994 | 4.0E-4 | 0 | 2024-05-10 | 105.0 - 114.6 | 0.0 | In |
Put | 2024-05-10 PUT at $530.0 | -0.9906 | 6.0E-4 | 0 | 2024-05-10 | 115.0 - 124.7 | 0.0 | In |
Put | 2024-05-10 PUT at $540.0 | -0.9767 | 0.001 | 0 | 2024-05-10 | 125.3 - 135.0 | 0.0 | In |
Put | 2024-05-10 PUT at $550.0 | -0.9914 | 5.0E-4 | 0 | 2024-05-10 | 135.0 - 144.7 | 0.0 | In |
Put | 2024-05-10 PUT at $560.0 | -0.9805 | 8.0E-4 | 0 | 2024-05-10 | 145.2 - 155.0 | 0.0 | In |
Put | 2024-05-10 PUT at $570.0 | -0.9832 | 7.0E-4 | 0 | 2024-05-10 | 155.1 - 165.0 | 0.0 | In |
Put | 2024-05-10 PUT at $580.0 | -0.9838 | 6.0E-4 | 0 | 2024-05-10 | 165.1 - 175.0 | 0.0 | In |
Vertex Pharmaceuticals Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Vertex Pharmaceuticals Common Stock Shares Outstanding Over Time
The total number of shares of a company's common stock that are currently owned by all its shareholders. Common Stock Shares Outstanding |
| Timeline |
Vertex Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vertex Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Rebalancing Now
Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets |
| All Next | Launch Module |
Vertex Pharmaceuticals Corporate Management
Elected by the shareholders, the Vertex Pharmaceuticals' board of directors comprises two types of representatives: Vertex Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Vertex. The board's role is to monitor Vertex Pharmaceuticals' management team and ensure that shareholders' interests are well served. Vertex Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Vertex Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jonathan JD | Executive Officer | Profile | |
| Stephanie Franklin | Senior Officer | Profile | |
| Mike Tirozzi | SVP Officer | Profile | |
| Damian Esq | Chief VP | Profile | |
| Ourania Tatsis | Ex Officer | Profile |
Already Invested in Vertex Pharmaceuticals?
The danger of trading Vertex Pharmaceuticals is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Vertex Pharmaceuticals is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Vertex Pharmaceuticals. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Vertex Pharmaceuticals is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Vertex Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vertex Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vertex Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vertex Pharmaceuticals Stock: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vertex Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Vertex Stock please use our How to Invest in Vertex Pharmaceuticals guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Vertex Stock analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Vertex Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vertex Pharmaceuticals. If investors know Vertex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vertex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.565 | Earnings Share 15.43 | Revenue Per Share 39.492 | Quarterly Revenue Growth 0.133 | Return On Assets 0.1281 |
The market value of Vertex Pharmaceuticals is measured differently than its book value, which is the value of Vertex that is recorded on the company's balance sheet. Investors also form their own opinion of Vertex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Vertex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vertex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Vertex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vertex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Vertex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vertex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.